212 related articles for article (PubMed ID: 32732300)
21. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
[TBL] [Abstract][Full Text] [Related]
22. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.
Yassi N; Hilal S; Xia Y; Lim YY; Watson R; Kuijf H; Fowler C; Yates P; Maruff P; Martins R; Ames D; Chen C; Rowe CC; Villemagne VL; Salvado O; Desmond PM; Masters CL
J Alzheimers Dis; 2020; 73(3):897-907. PubMed ID: 31884485
[TBL] [Abstract][Full Text] [Related]
23. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
[TBL] [Abstract][Full Text] [Related]
24. Executive function mediates effects of white matter hyperintensities on episodic memory.
Parks CM; Iosif AM; Farias S; Reed B; Mungas D; DeCarli C
Neuropsychologia; 2011 Aug; 49(10):2817-24. PubMed ID: 21689669
[TBL] [Abstract][Full Text] [Related]
25. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
[TBL] [Abstract][Full Text] [Related]
26. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
[TBL] [Abstract][Full Text] [Related]
27. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
28. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
[TBL] [Abstract][Full Text] [Related]
29. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
30. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
[TBL] [Abstract][Full Text] [Related]
31. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
[TBL] [Abstract][Full Text] [Related]
32. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
[TBL] [Abstract][Full Text] [Related]
33. Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults.
Schaeverbeke JM; Gabel S; Meersmans K; Luckett ES; De Meyer S; Adamczuk K; Nelissen N; Goovaerts V; Radwan A; Sunaert S; Dupont P; Van Laere K; Vandenberghe R
Alzheimers Res Ther; 2021 Apr; 13(1):75. PubMed ID: 33827690
[TBL] [Abstract][Full Text] [Related]
34. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
35. Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.
Lane CA; Barnes J; Nicholas JM; Sudre CH; Cash DM; Malone IB; Parker TD; Keshavan A; Buchanan SM; Keuss SE; James SN; Lu K; Murray-Smith H; Wong A; Gordon E; Coath W; Modat M; Thomas D; Richards M; Fox NC; Schott JM
JAMA Neurol; 2020 Feb; 77(2):175-183. PubMed ID: 31682678
[TBL] [Abstract][Full Text] [Related]
36. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
[TBL] [Abstract][Full Text] [Related]
37. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
38. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
[TBL] [Abstract][Full Text] [Related]
39. New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease.
Zhuo J; Zhang Y; Liu Y; Liu B; Zhou X; Bartlett PF; Jiang T;
Cereb Cortex; 2021 Jun; 31(7):3363-3373. PubMed ID: 33690839
[TBL] [Abstract][Full Text] [Related]
40. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
